This past Friday, February 7, the Bureau of Labor Statistics released the January jobs numbers – and the results were gangbusters. With 225,000 …
The bull market is charging on, with the Dow Jones, NASDAQ, and S&P 500 indexes all closing out last week by recording new …
It was a short and dramatic plunge for Johnson & Johnson (JNJ). The stock lost over 10% of its value following a Reuters report …
By Bob Ciura The Internet holds a wealth of information to investors looking for dividend stocks. Considering the many web sites that publish …
The U.S.
Now that 2016 is coming to an end, I am very excited to ring in the New Year. Putting back up the Christmas …
In my latest article, I told you my little secret about selling any stock at the right time. In fact, it’s not about …
Maxim analyst Jason McCarthy reiterated a Hold rating on shares of pharmaceutical giant Gilead Sciences, Inc (NASDAQ:GILD), after discussing with GILD management about the …
Analysts provide insights on healthcare giants Celgene Corporation (NASDAQ:CELG) and Johnson & Johnson (NYSE:JNJ), following an amended agreement and an investor day, respectively. One …
By Brett Eversole Quality companies are going on sale. Investors are scared.
